Minocycline-induced cutaneous hyperpigmentation in an orthopedic patient population

Open Forum Infectious Diseases

Volumn 3, Issue 1, 2016, Pages

  Hanada, Yuri ^a   Berbari, Elie F ^a   Steckelberg, James M ^a  

^a MAYO CLINIC   (United States)

Author keywords

Antimicrobial side effects; Minocycline; Orthopedic infections

Indexed keywords

MINOCYCLINE;

AFRICAN AMERICAN; AGED; ARTICLE; BLUE BLACK PIGMENTATION; BLUE GRAY PIGMENTATION; BROWN PIGMENTATION; CAUCASIAN; FEMALE; FOLLOW UP; HUMAN; HYPERPIGMENTATION; INFECTIOUS ARTHRITIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SENSITIVE STAPHYLOCOCCUS EPIDERMIDIS; METHICILLIN-RESISTANT STAPHYLOCOCCUS EPIDERMIDIS; MUSCULOSKELETAL DISEASE; PRIORITY JOURNAL; PROSTHESIS INFECTION; RISK FACTOR; SHOULDER PROSTHESIS; SKIN PIGMENTATION; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT DURATION; VITAMIN D DEFICIENCY;

EID: 85000609394     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofv107     Document Type: Article

References (20)

1. Patterson JW, Wilson B, Wick MR, Heath C. Hyperpigmented scar due to minocycline therapy. Cutis 2004; 74:293-8
2. Bowen AR, McCalmont TH. The histopathology of subcutaneous minocycline pigmentation. J Am Acad Dermatol 2007; 57:836-9
3. Dwyer CM, Cuddihy AM, Kerr RE, et al. Skin pigmentation due to minocycline treatment of facial dermatoses. Br J Dermatol 1993; 129:158-62
4. Goulden V, Glass D, Cunliffe WJ. Safety of long-term high-dose minocycline in the treatment of acne. Br J Dermatol 1996; 134:693-5
5. Roberts G, Capell HA. The frequency and distribution of minocycline induced hyperpigmentation in a rheumatoid arthritis population. J Rheumatol 2006; 33:1254-7
6. Fay BT, Whiddon AP, Puumala S, et al. Minocycline-induced hyperpigmentation in rheumatoid arthritis. J Clin Rheumatol 2008; 14:17-20
7. Fenske NA, Millns JL, Greer KE. Minocycline-induced pigmentation at sites of cutaneous inflammation. JAMA 1980; 244:1103-6
8. McGrae JD Jr, Zelickson AS. Skin pigmentation secondary to minocycline therapy Arch Dermatol 1980; 116:1262-5
9. Mouton RW, Jordaan HF, Schneider JW. A new type of minocycline-induced cutaneous hyperpigmentation. Clin Exp Dermatol 2004; 29:8-14
10. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol 2003; 49(1 Suppl):S1-37
11. Tan HH. Antibacterial therapy for acne: a guide to selection and use of systemic agents. Am J Clin Dermatol 2003; 4:307-14
12. Knoell KA, Milgraum SS, Kutenplon M. Q-switched ruby laser treatment of minocycline-induced cutaneous hyperpigmentation. Arch Dermatol 1996; 132: 1251-3
13. Greve B, Schonermark MP, Raulin C. Minocycline-induced hyperpigmentation: treatment with the Q-switched Nd:YAG laser. Lasers Surg Med 1998; 22: 223-7
14. Alster TS, Gupta SN. Minocycline-induced hyperpigmentation treated with a 755- nm Q-switched alexandrite laser. Dermatol Surg 2004; 30:1201-4
15. Nisar MS, Iyer K, Brodell RT, et al. Minocycline-induced hyperpigmentation: comparison of 3 Q-switched lasers to reverse its effects. Clin Cosmet Investig Dermatol 2013; 6:159-62
16. Agwuh KN, MacGowan A. Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J Antimicrob Chemother 2006; 58:256-65
17. Bowles WH. Protection against minocycline pigment formation by ascorbid acid (vitamin C). J Esthet Dent 1998; 10:182-6
18. Shahriari M, Kerr PE, Slade K, Grant-Kels JE. Vitamin D and the skin. Clin Dermatol 2010; 28:663-8
19. Ortiz A, Grando SA. Smoking and the skin. Int J Dermatol 2012; 51:250-62
20. Sorensen LT. Wound healing and infection in surgery. The clinical impact of smoking and smoking cessation: a systematic review and meta-analysis. Arch Surg 2012; 147:373-83